|
"su jl"的相关文件
显示项目 26-35 / 55 (共6页)
<< < 1 2 3 4 5 6 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2014-06 |
The anti-tumor activity of E1A and its implications in cancer therapy
|
Chang, YW;Hung, MC;Su, JL |
| 國家衛生研究院 |
2014-05-20 |
Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects
|
Chang, YW;Su, CM;Su, YH;Ho, YS;Lai, HH;Chen, HA;Kuo, ML;Hung, WC;Chen, YW;Wu, CH;Chen, PS;Su, JL |
| 國家衛生研究院 |
2014-03 |
Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment
|
Chen, CK;Yang, CY;Hua, KT;Ho, MC;Johansson, G;Jeng, YM;Chen, CN;Chen, MW;Lee, WJ;Su, JL;Lai, TC;Chou, CC;Ho, BC;Chang, CF;Lee, PH;Chang, KJ;Hsiao, M;Lin, MT;Kuo, ML |
| 國立臺灣大學 |
2011-02 |
N-α-acetyltransferase 10 protein suppresses cancer cell metastasis by binding PIX proteins and inhibiting Cdc42/Racl activity.
|
Hua KT; Tan CT; Johansson G; Lee JM; Yang PW; Lu HY; Chen CK; Su JL; Chen PB; Wu YL; Chi CC; Kao HJ; Shih HJ; Chen MW; Chien MH; Chen PS; Lee WJ; Cheng TY; Rosenberger G; Chai CY; Yang CJ; Huang MS; Lai TC; Chou TY; Hsiao M; Kuo ML; 華國泰; 譚慶鼎; 李章銘; 蘇振良; 陳柏森; 吳玉玲; 紀佳君; 蕭宏昇; 郭明良 |
| 高雄醫學大學 |
2011 |
N-α-acetyltransferase 10 protein 藉由結合 PIX proteins and inhibiting Cdc42/Rac1 activity來壓制癌症轉移.
|
華國泰;譚慶鼎;李章銘;蘇振良;陳柏森;吳玉玲;紀佳君;蔡志仁;楊志仁;黃明賢;蕭宏昇;郭明良 ; Hua KT;Tan CT;Johansson G;Lee JM;Yang PW;Lu HY;Chen CK;Su JL;Chen PB;Wu YL;Chi CC;Kao HJ;Shih HJ;Chen MW;Chien MH;Chen PS;Lee WJ;Cheng TY;Rosenberger G;Chai CY;Yang CJ;Huang MS;Lai TC;Chou TY;Hsiao M;Kuo ML |
| 中山醫學大學 |
2010 |
Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells.
|
Yang, SF; Chen, MK; Hsieh, YS; Chung, TT; Hsieh, YH; Lin, CW; Su, JL; Tsai, MH; Tang, CH |
| 國立臺灣大學 |
2008-06 |
Further evidence for expression and function of the VEGF-C/VEGFR-3 axis in cancer cells.
|
Su, JL; Chen, PS; Chien, MH; Chen, PB; Chen, YH; Lai, CC; Hung, MC; Kuo, ML. |
| 國立臺灣大學 |
2007-12 |
CTGF enhances the motility of breast cancer cells via an integrin-{alpha}vbeta3-ERK1/2-dependent S100A4-upregulated pathway.
|
Chen, PS; Wang, MY; Wu, SN; Su, JL; Hong, CC; Chuang, SE; Chen, MW; Hua, KT; Wu, YL; Cha, ST; Babu, MS; Chen, CN; Lee, PH; Chang, KJ; Kuo, ML |
| 國家衛生研究院 |
2007-06-15 |
CTGF enhances the motility of breast cancer cells via an integrin-alpha v beta 3-ERK1/2-dependent S100A4-upregulated pathway
|
Chen, PS; Wang, MY; Wu, SN; Su, JL; Hong, CC; Chuang, SE; Chen, MW; Hua, KT; Wu, YL; Cha, ST; Babu, MS; Chen, CN; Lee, PH; Chang, KJ; Kuo, ML |
| 國家衛生研究院 |
2007-02-26 |
The role of the VEGF-C/VEGFR-3 axis in cancer progression
|
Su, JL; Yen, CJ; Chen, PS; Chuang, SE; Hong, CC; Kuo, IH; Chen, HY; Hung, MC; Kuo, ML |
显示项目 26-35 / 55 (共6页)
<< < 1 2 3 4 5 6 > >>
每页显示[10|25|50]项目
|
